Angeliki P Kourounakis (Angeliki Kourounakis)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Cardiovascular Risk Factors

Top Venues

Bioengineering (Basel, Switzerland)

Medicinal research reviews

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Dimitrios Bakalis, George Lamprinidis, Angeliki P Kourounakis, George Manis
Contribution of Deep Learning in the Investigation of Possible Dual LOX-3 Inhibitors/DPPH Scavengers: The Case of Recently Synthesized Compounds. Bioengineering (Basel, Switzerland) 9 (12) (2022)
Vassiliki-Panagiota Tassopoulou, Ariadni Tzara, Angeliki P Kourounakis
Design of Improved Antidiabetic Drugs: A Journey from Single to Multitarget Agents. ChemMedChem (2022)
Dimitrios Bakalis, George Lamprinidis, Angeliki P Kourounakis, George Manis
Contribution of Deep Learning in the Investigation of Possible Dual LOX-3 Inhibitors/DPPH Scavengers: The Case of Recently Synthesized Compounds. Bioengineering (Basel, Switzerland) 9 (12) (2022)
Angeliki P Kourounakis, Eugenia Bavavea
New applications of squalene synthase inhibitors: Membrane cholesterol as a therapeutic target. Archiv der Pharmazie 353 (9) (2020)
Ariadni Tzara, Dimitrios Xanthopoulos, Angeliki P Kourounakis
Morpholine As a Scaffold in Medicinal Chemistry: An Update on Synthetic Strategies. ChemMedChem 15 (5) (2020)
Angeliki P Kourounakis, Dimitrios Xanthopoulos, Ariadni Tzara
Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules. Medicinal research reviews 40 (2) (2019)